2m 2m 2m 2m 2m 2m 2m
TSCAN THERAPEUT (TCRX)
NASDAQ
$1.05+$0.02 (+1.94%)
Price as of Jul 14, 2026 4:43 AM EDT- $62.9MMarket Cap
- -46.35%1-Year Change
- BiotechnologyIndustry
TSCAN THERAPEUT (TCRX)
$1.05+$0.02 (+1.94%)
TCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.03 | ||
Change | -$0.06 (-5.50%) | ||
Open | $1.07 | ||
High | $1.10 | ||
Low | $1.02 | ||
Previous Close | $1.09 | ||
Volume | 1,152,419 | ||
30-Day Average Volume | 964,476 | ||
1-Week Change | -1.90% | ||
1-Month Change | 12.93% | ||
1-Year Change | -46.35% | ||
3-Year Change | -53.60% | ||
5-Year Change | -95.89% | ||
Fundamentals | |||
Shares Outstanding | 61.1M | ||
Total Assets | $202.0M | ||
Market Cap | $62.9M | ||
Enterprise Value | -$32.5M | ||
Period: QTR TTM FY | |||
Revenue | $982,000.00 | ||
Net Income | -$28.7M | ||
Free Cash Flow | -$24.3M | ||
EBIT | -$28.0M | ||
EBITDA | -$27.3M | ||
Net Working Capital | $112.8M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -33 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue